What Researchers Did
Researchers described the successful treatment of pyoderma gangrenosum with hyperbaric oxygen therapy in a single patient.
What They Found
In one patient with severe rheumatoid arthritis and diabetes mellitus, hyperbaric oxygen therapy promoted the healing of pyoderma gangrenosum. This therapy also allowed for a reduction in the patient's systemic corticosteroid dosage.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be considered as an alternative or adjunctive treatment option for Canadian patients suffering from pyoderma gangrenosum, especially those with comorbidities. This approach might help reduce reliance on systemic corticosteroids, potentially minimizing their side effects.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
The primary limitation of this study is its design as a single case report, which limits the generalizability of the findings to a broader patient population.